377 related articles for article (PubMed ID: 11726317)
21. Identification of CD123+ myeloid dendritic cells as an early-stage immature subset with strong tumoristatic potential.
Shi J; Ikeda K; Maeda Y; Shinagawa K; Ohtsuka A; Yamamura H; Tanimoto M
Cancer Lett; 2008 Oct; 270(1):19-29. PubMed ID: 18555589
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-3 receptor α chain (CD123) is preferentially expressed in immature T-ALL and may not associate with outcomes of chemotherapy.
Du W; Li J; Liu W; He Y; Yao J; Liu Y; Lin J; Zheng J
Tumour Biol; 2016 Mar; 37(3):3817-21. PubMed ID: 26474588
[TBL] [Abstract][Full Text] [Related]
23. BAFF-R, the major B cell-activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders.
Rodig SJ; Shahsafaei A; Li B; Mackay CR; Dorfman DM
Hum Pathol; 2005 Oct; 36(10):1113-9. PubMed ID: 16226112
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric analysis of CD123 is useful for immunophenotyping classical Hodgkin lymphoma.
Fromm JR
Cytometry B Clin Cytom; 2011 Mar; 80(2):91-9. PubMed ID: 20809502
[TBL] [Abstract][Full Text] [Related]
25. The CMRF58 antibody recognizes a subset of CD123hi dendritic cells in allergen-challenged mucosa.
Vuckovic S; Khalil D; Angel N; Jahnsen F; Hamilton I; Boyce A; Hock B; Hart DN
J Leukoc Biol; 2005 Mar; 77(3):344-51. PubMed ID: 15569693
[TBL] [Abstract][Full Text] [Related]
26. C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.
Bakker AB; van den Oudenrijn S; Bakker AQ; Feller N; van Meijer M; Bia JA; Jongeneelen MA; Visser TJ; Bijl N; Geuijen CA; Marissen WE; Radosevic K; Throsby M; Schuurhuis GJ; Ossenkoppele GJ; de Kruif J; Goudsmit J; Kruisbeek AM
Cancer Res; 2004 Nov; 64(22):8443-50. PubMed ID: 15548716
[TBL] [Abstract][Full Text] [Related]
27. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
[TBL] [Abstract][Full Text] [Related]
28. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
29. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies.
Bueno C; Almeida J; Lucio P; Marco J; Garcia R; de Pablos JM; Parreira A; Ramos F; Ruiz-Cabello F; Suarez-Vilela D; San Miguel JF; Orfao A
Haematologica; 2004 Jan; 89(1):58-69. PubMed ID: 14754607
[TBL] [Abstract][Full Text] [Related]
30. Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia.
Tamura H; Dan K; Tamada K; Nakamura K; Shioi Y; Hyodo H; Wang SD; Dong H; Chen L; Ogata K
Clin Cancer Res; 2005 Aug; 11(16):5708-17. PubMed ID: 16115907
[TBL] [Abstract][Full Text] [Related]
31. Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.
Torelli GF; Guarini A; Maggio R; Alfieri C; Vitale A; Foà R
Haematologica; 2005 Jun; 90(6):785-92. PubMed ID: 15951291
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
[TBL] [Abstract][Full Text] [Related]
33. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
34. Selectively increased expression and functions of chemokine receptor CCR9 on CD4+ T cells from patients with T-cell lineage acute lymphocytic leukemia.
Qiuping Z; Qun L; Chunsong H; Xiaolian Z; Baojun H; Mingzhen Y; Chengming L; Jinshen H; Qingping G; Kejian Z; Zhimin S; Xuejun Z; Junyan L; Jinquan T
Cancer Res; 2003 Oct; 63(19):6469-77. PubMed ID: 14559839
[TBL] [Abstract][Full Text] [Related]
35. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
36. C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia.
Auewarakul CU; Lauhakirti D; Promsuwicha O; Munkhetvit C
Ann Hematol; 2006 Feb; 85(2):108-12. PubMed ID: 16320053
[TBL] [Abstract][Full Text] [Related]
37. Short-term Flt3L treatment effectively mobilizes functional macaque dendritic cells.
Teleshova N; Jones J; Kenney J; Purcell J; Bohm R; Gettie A; Pope M
J Leukoc Biol; 2004 Jun; 75(6):1102-10. PubMed ID: 15075365
[TBL] [Abstract][Full Text] [Related]
38. Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies.
Kokhaei P; Abdalla AO; Hansson L; Mikaelsson E; Kubbies M; Haselbeck A; Jernberg-Wiklund H; Mellstedt H; Osterborg A
Clin Cancer Res; 2007 Jun; 13(12):3536-44. PubMed ID: 17575216
[TBL] [Abstract][Full Text] [Related]
39. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
Sánchez-García J; Serrano J; Gómez P; Martínez F; Martín C; Román-Gómez J; Rodríguez A; Herrera C; García JM; Alvarez MA; Torres A
Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
